tiprankstipranks
Shandong Weigao Group Medical Polymer Co Ltd Class H (HK:1066)
:1066
Hong Kong Market
Want to see HK:1066 full AI Analyst Report?

Shandong Weigao Group Medical Polymer Co (1066) Financial Statements

3 Followers

Shandong Weigao Group Medical Polymer Co Financial Overview

Shandong Weigao Group Medical Polymer Co's market cap is currently HK$15.65B. The company's EPS TTM is HK$0.35; its P/E ratio is 12.88; and it has a dividend yield of 4.58%. Shandong Weigao Group Medical Polymer Co is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 13.39B¥ 13.09B¥ 13.23B¥ 13.62B¥ 13.15B
Gross Profit¥ 6.33B¥ 6.58B¥ 6.64B¥ 7.31B¥ 7.35B
Operating Income¥ 1.70B¥ 2.39B¥ 2.04B¥ 2.92B¥ 2.89B
EBITDA¥ 2.75B¥ 3.14B¥ 3.55B¥ 4.38B¥ 3.75B
Net Income¥ 1.61B¥ 2.07B¥ 2.00B¥ 2.76B¥ 2.28B
Balance Sheet
Cash & Short-Term Investments¥ 9.87B¥ 8.32B¥ 7.33B¥ 7.49B¥ 7.13B
Total Assets¥ 36.06B¥ 34.76B¥ 33.67B¥ 33.20B¥ 30.37B
Total Debt¥ 5.99B¥ 4.19B¥ 4.17B¥ 4.49B¥ 4.14B
Net Debt¥ -3.00B¥ -3.59B¥ -2.82B¥ -2.37B¥ -2.49B
Total Liabilities¥ 10.23B¥ 9.42B¥ 9.68B¥ 9.75B¥ 9.46B
Stockholders' Equity¥ 24.12B¥ 23.75B¥ 22.45B¥ 21.67B¥ 19.27B
Cash Flow
Free Cash Flow¥ 1.72B¥ 2.19B¥ 2.11B¥ 1.10B¥ 1.92B
Operating Cash Flow¥ 2.55B¥ 2.79B¥ 2.80B¥ 2.21B¥ 3.04B
Investing Cash Flow¥ -382.91M¥ -1.10B¥ -1.39B¥ -2.57B¥ -1.48B
Financing Cash Flow¥ -772.65M¥ -1.60B¥ -2.16B¥ -1.02B¥ -547.92M
Currency in CNY

Shandong Weigao Group Medical Polymer Co Earnings and Revenue History

Shandong Weigao Group Medical Polymer Co Debt to Assets

Shandong Weigao Group Medical Polymer Co Cash Flow

Shandong Weigao Group Medical Polymer Co Forecast EPS vs Actual EPS